摘要
Background: Alzheimer's disease (AD) is a severe neurodegenerative disorder that progressively destroys cognitive skills. Exploring the mechanism underlying autophagic clearance of phosphorylated tau (p-Tau) contributes to developing novel therapeutic strategies for AD. Methods: SH-SY5Y and HT22 cells were treated with A beta 1-42 to establish an in vitro model of AD. Cell viability was examined using CCK-8. TUNEL staining was applied to evaluate cell apoptosis. LC3 puncta was examined by IF staining. m6A modification level was evaluated through MeRIP. RNA pull-down and RIP assays were used for analyzing the interaction between IGF2BP1 and STUB1 transcripts. The binding of KDM1A to the promoter of METTL3 was confirmed by ChIP assays. APP/PS1 transgenic mice were used as an in vivo model of AD. Cognitive skills of mice were evaluated with the Morris water maze. Hippocampal damage and A beta deposition were detected through H&E and IHC staining. Results: Dysregulated levels of autophagy, p-Tau and m6A was observed in an in vitro model of AD. Overexpression of METTL3 or STUB1 enhanced autophagy but reduced p-Tau level in A beta 1-42-treated cells. METTL3 stabilized STUB1 mRNA through the m6A-IGF2BP1-dependent mechanism and naturally promoted STUB1 expression, thereby enhancing autophagic p-Tau clearance in A beta 1-42-treated cells. Overexpression of KDM1A enhanced autophagy, m6A modification and autophagic p-Tau clearance in A beta 1-42-treated cells. KDM1Amediated upregulation of METTL3 promoted autophagic p-Tau clearance and ameliorated Alzheimer's disease both in vitro and in vivo. Conclusion: KDM1A-mediated upregulation of METTL3 enhances autophagic clearance of p-Tau through m6Adependent regulation of STUB1, thus ameliorating Alzheimer's disease. Our study provides novel mechanistic insights into AD pathogenesis and potential drug targets for AD.
学科与关键词
- The Landscape of m6A Regulators in Multiple Brain Regions of Alzheimer's DiseaseLiu, ZiJie; Xia, Qing; Zhao, Xue; Zheng, FeiFei; Xiao, JiaYing; Ge, FangLiang; Wang, DaYong*; Gao, Xu*Molecular Neurobiology, 2023, 60(9): 5184-5198.被引 2
- MicroRNA-140 silencing represses the incidence of Alzheimer's diseaseLiang, Chunming*; Mu, Yuyuan; Tian, Hua; Wang, Dan; Zhang, Shicun; Wang, Hongjiao; Liu, Yang; Di, CihanNeuroscience Letters, 2021, 758: 135674.被引 13
- Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potentialZhang, Wei; Xu, Chengchao; Sun, Jichao; Shen, Han-Ming*; Wang, Jigang*; Yang, Chuanbin*Acta Pharmaceutica Sinica B, 2022, 12(3): 1019-1040.被引 49
